During the past decade, Ogaki Municipal Hospital conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 18 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 13 clinical trials were completed. i.e. 44.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ogaki Municipal Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 10 trials, followed by "Boehringer Ingelheim" with 7 trials sponsored, "Celgene" with 7 trials sponsored, "Amgen" with 6 trials sponsored and "Bayer" with 6 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ogaki Municipal Hospital" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Ogaki Municipal Hospital" are "Multiple Myeloma" (7 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (3 trials), "Myelodysplastic Syndromes" (3 trials) and "Relapsed or Refractory Multiple Myeloma" (3 trials). Many other conditions were trialed in "Ogaki Municipal Hospital" in a lesser frequency.

Most popular intervention types in "Ogaki Municipal Hospital" are "Drug" (50 trials), "Other" (5 trials), "Device" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Dexamethasone" (10 trials), "Bortezomib" (7 trials), "Carfilzomib" (7 trials) and "Daratumumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ogaki Municipal Hospital" are 59 trials for "All" genders.

Currently, there are NaN active trials in "Ogaki Municipal Hospital". undefined are not yet recruiting, 17 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ogaki Municipal Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ogaki Municipal Hospital, 5 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".